IDEXX Laboratories, Inc., founded in 1983 by David Evans Shaw, is a global leader in veterinary diagnostics and testing solutions. The company develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing markets. Operating through segments like Companion Animal Group, Water Quality Products, and Livestock, Poultry, and Dairy, IDEXX provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits.
IDEXX has made significant strides in the healthcare industry, with a revenue of $3.66 billion and a net income of $845 million in 2023. The company is publicly traded on Nasdaq under the ticker IDXX and is a component of both the Nasdaq-100 and S&P 500. Under the leadership of CEO Jay Mazelsky and Chairman Lawrence Kingsley, IDEXX has established an international network of labs, helping veterinary professionals practice at their best by offering advanced diagnostic tools and insights.
